Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021)

Historic Treasury Shares for TScan Therapeutics (TCRX) over the last 2 years, with Q4 2021 value amounting to $116870.0.

  • TScan Therapeutics' Treasury Shares fell 7333.44% to $116870.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $116870.0, marking a year-over-year decrease of 7333.44%. This contributed to the annual value of $116870.0 for FY2021, which is 7333.44% down from last year.
  • TScan Therapeutics' Treasury Shares amounted to $116870.0 in Q4 2021, which was down 7333.44% from $204513.0 recorded in Q3 2021.
  • Over the past 5 years, TScan Therapeutics' Treasury Shares peaked at $438280.0 during Q4 2020, and registered a low of $116870.0 during Q4 2021.